サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1258154

個別化医療の世界市場規模の調査・予測、製品別（個別化医療診断、個別化医療治療、個別化医療ケア、個別化栄養・ウェルネス）、地域別分析、2022-2029年

Global Personalized Medicine Market Size study & Forecast, by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
個別化医療の世界市場規模の調査・予測、製品別（個別化医療診断、個別化医療治療、個別化医療ケア、個別化栄養・ウェルネス）、地域別分析、2022-2029年
出版日: 2023年04月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の個別化医療市場は、2021年に約5,143億3,000万米ドルと評価され、予測期間2022-2029年には6.95%以上の健全な成長率で成長すると予測されています。

個別化医療は精密医療とも呼ばれ、人々を異なるグループに分け、患者の予想される反応や病気のリスクに応じて、医療上の決定、治療、実践、および/または製品を各患者に合わせるものです。この市場は、新薬開発に対する需要の高まり、がん患者数の増加、その他の疾患によって大きく牽引されています。また、臨床試験件数の増加が、予測期間2022-2029年の市場成長を牽引しています。さらに、主要な市場関係者による取り組みが活発化していることも、この期間の市場に有利な成長機会をもたらしています。

また、希少疾患の蔓延が市場の拡大を加速させると予測されています。多くの個別化医療や治療活動の開発は、ヒトゲノムの特性に対する理解と相関の進歩によって可能になりました。例えば、2022年9月にカリフォルニア大学アーバイン校で行われた研究では、個人のニーズに高度に対応した精密なゲノム編集を適用することにより、遺伝性網膜疾患（IRD）を治療する独自の方法が提示されました。これに伴い、FDAの承認を取得したコンパニオン診断薬も増加しています。例えば、ロシュは2020年10月に「コバスEGFR変異検査」の非小細胞肺がん治療への使用拡大について米国FDAの認可を取得しました。しかし、個別化医療の高コストが、2022-2029年の予測期間を通じて市場成長を阻害しています。

世界の個別化医療市場の調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカを含みます。2021年には、北米が最大のシェアを占めています。これは、大手製薬会社や研究組織からの資金提供につながっています。あらゆる種類の病気は、現在、個別化医療で治療するのが最善であり、そのため、あらゆる症状に対する創薬や調査には、現在、個別化医療が含まれています。この地域では、診断のための個別化医療が進んでいます。アジア太平洋地域では、増加する疾病の蔓延に対抗するため、個別化診断や新規治療薬に対する需要が高まっており、予測期間中に最も急速に拡大すると予想されています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 個別化医療市場、地域別、2019-2029年
    • 個別化医療市場、製品別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 世界の個別化医療市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 世界の個別化医療市場力学

  • 個別化医療市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 希少疾患の普及が進む
      • 増え続ける臨床試験
      • 新規創薬への需要の高まり
    • 市場の課題
      • 個別化医療にかかる高いコスト
    • 市場機会
      • 主要な市場プレイヤーのイニシアティブの高まり

第4章 世界の個別化医療市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 投資採用モデル
  • アナリストの提言と結論
  • 主な投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 個別化医療の世界市場：製品別

  • マーケットスナップショット
  • 個別化医療の世界市場：製品別、実績-ポテンシャル分析
  • 世界の個別化医療市場の製品別推定・予測2019-2029
  • 個別化医療市場、サブセグメント分析
    • 個別化医療診断
    • 個別化医療治療
    • 個別化医療ケア
    • 個別化栄養・ウェルネス

第7章 個別化医療の世界市場：地域別分析

  • 個別化医療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の個別化医療市場のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の個別化医療市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの個別化医療市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • GE Healthcare
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Illumina, Inc.
    • ASURAGEN, INC.
    • Abbott
    • Dako A/S
    • Exact Sciences Corporation
    • Danaher Corporation（Cepheid, Inc.）
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.

第9章 調査のプロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Personalized Medicine Market, report scope
  • TABLE 2. Global Personalized Medicine Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Personalized Medicine Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Personalized Medicine Market
  • TABLE 69. List of primary sources, used in the study of global Personalized Medicine Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Personalized Medicine Market, research methodology
  • FIG 2. Global Personalized Medicine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Personalized Medicine Market, key trends 2021
  • FIG 5. Global Personalized Medicine Market, growth prospects 2022-2029
  • FIG 6. Global Personalized Medicine Market, porters 5 force model
  • FIG 7. Global Personalized Medicine Market, pest analysis
  • FIG 8. Global Personalized Medicine Market, value chain analysis
  • FIG 9. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Personalized Medicine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Personalized Medicine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Personalized Medicine Market is valued approximately USD 514.33 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.95% over the forecast period 2022-2029. Personalised medicine, is also known as precision medicine, it divides people into distinct groups and then tailors medical decisions, therapies, practises, and/or products to each patient depending on that patient's expected response or illness risk. The market is majorly driven by rising demand for novel drug discovery, rising number of cancer cases and other diseases. Along with this, growing number of clinical trials is driving the growth for the market over the forecast period 2022-2029. Moreover, rising initiatives by key market players is creating lucrative growth opportunity for the market over the period.

It is also projected that the rising prevalence of rare diseases will accelerate market expansion. The development of numerous individualized medical treatments and therapeutic activities has been made possible by advances in our understanding and correlation of the properties of the human genome. For instance, a research study conducted at the University of California, Irvine in September 2022 offered a unique method for treating inherited retinal diseases (IRDs) by applying precise genome editing that is highly tailored to the needs of an individual. Along with this, there are an increasing number of companion diagnostics that have received FDA approval. For example, Roche received U.S. FDA clearance in October 2020 to expand the use of the Cobas EGFR Mutation Test for the treatment of non-small cell lung cancer. However, the high cost of Personalized Medicine stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Personalized Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2021, North America had the largest share. This is linked to funding from large pharmaceutical companies and research organisations. All types of ailments are now best treated with personalised medicine, which is why drug discovery and research into any condition now include it. In the region, personalised medicine is advancing for diagnostic purposes. Due to rising demand for personalised diagnostics and novel treatment medications to combat the region's rising disease prevalence, Asia Pacific is anticipated to have the fastest expanding segment over the course of the projection year.

Major market players included in this report are:

  • GE Healthcare
  • Illumina, Inc.
  • ASURAGEN, INC.
  • Abbott
  • Dako A/S
  • Exact Sciences Corporation
  • Danaher Corporation (Cepheid, Inc.)
  • Decode Genetics, Inc.
  • QIAGEN
  • Exagen Inc.

Recent Developments in the Market:

  • In order to create personalised nutrition for healthcare providers and their subjects using a high-end technology interface, Panaceutics Nutrition and Viocare announced a collaborative agreement in January 2022. This agreement will combine Viocare's nutrition assessment software with personalised nutrition supplementation to create an end-to-end service platform.
  • Genomic Medicine Sweden (GMS) and the Centers for Personalized Medicine (ZPM) in Germany joined up in February 2022 to apply precision medicine in healthcare in strategic, structural, and content-specific ways.

Global Personalized Medicine Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Personalized Medicine Diagnostics
  • Personalized Medicine Therapeutics
  • Personalized Medical Care
  • Personalized Nutrition & Wellness

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Personalized Medicine Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Personalized Medicine Market, by Product, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Personalized Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Personalized Medicine Market Dynamics

  • 3.1. Personalized Medicine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of rare disease
      • 3.1.1.2. Growing number of clinical trials
      • 3.1.1.3. Rising demand for novel drug discovery
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Personalized Medicine
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising initiatives by key market players

Chapter 4. Global Personalized Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Personalized Medicine Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Personalized Medicine Market by Product, Performance - Potential Analysis
  • 6.3. Global Personalized Medicine Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Personalized Medicine Market, Sub Segment Analysis
    • 6.4.1. Personalized Medicine Diagnostics
    • 6.4.2. Personalized Medicine Therapeutics
    • 6.4.3. Personalized Medical Care
    • 6.4.4. Personalized Nutrition & Wellness

Chapter 7. Global Personalized Medicine Market, Regional Analysis

  • 7.1. Personalized Medicine Market, Regional Market Snapshot
  • 7.2. North America Personalized Medicine Market
    • 7.2.1. U.S. Personalized Medicine Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Personalized Medicine Market
  • 7.3. Europe Personalized Medicine Market Snapshot
    • 7.3.1. U.K. Personalized Medicine Market
    • 7.3.2. Germany Personalized Medicine Market
    • 7.3.3. France Personalized Medicine Market
    • 7.3.4. Spain Personalized Medicine Market
    • 7.3.5. Italy Personalized Medicine Market
    • 7.3.6. Rest of Europe Personalized Medicine Market
  • 7.4. Asia-Pacific Personalized Medicine Market Snapshot
    • 7.4.1. China Personalized Medicine Market
    • 7.4.2. India Personalized Medicine Market
    • 7.4.3. Japan Personalized Medicine Market
    • 7.4.4. Australia Personalized Medicine Market
    • 7.4.5. South Korea Personalized Medicine Market
    • 7.4.6. Rest of Asia Pacific Personalized Medicine Market
  • 7.5. Latin America Personalized Medicine Market Snapshot
    • 7.5.1. Brazil Personalized Medicine Market
    • 7.5.2. Mexico Personalized Medicine Market
  • 7.6. Rest of The World Personalized Medicine Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. GE Healthcare
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Illumina, Inc.
    • 8.2.3. ASURAGEN, INC.
    • 8.2.4. Abbott
    • 8.2.5. Dako A/S
    • 8.2.6. Exact Sciences Corporation
    • 8.2.7. Danaher Corporation (Cepheid, Inc.)
    • 8.2.8. Decode Genetics, Inc.
    • 8.2.9. QIAGEN
    • 8.2.10. Exagen Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption